Effectiveness and Safety Study of Specific Hyperimmune Equine Serum for the Treatment of Severe Hospitalized SARS-CoV-2 in Adults: Retrospective Cohort Study
Clinical trial NCT04954235 · COMPLETED
Trial details
- NCT number
- NCT04954235
- Sponsor
- Inmunova S.A.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-22
- Primary completion
- 2021-09-09
- Enrollment
- 847
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.